PROTAGONIST THERAPEUTICS Trademark

Trademark Overview


On Wednesday, May 29, 2019, a trademark application was filed for PROTAGONIST THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PROTAGONIST THERAPEUTICS trademark a serial number of 88450820. The federal status of this trademark filing is REGISTERED as of Tuesday, September 1, 2020. This trademark is owned by Protagonist Therapeutics, Inc.. The PROTAGONIST THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

SCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; TECHNICAL AND SCIENTIFIC CONSULTATION AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS, IN THE FIELD OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND TO PHARMACEUTICALS; PROVIDING ON-LINE INFORMATION FOR MEDICAL RESEARCH PURPOSES, IN THE FIELDS OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, TREATMENTS FOR IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND PHARMACEUTICALS
protagonist therapeutics

General Information


Serial Number88450820
Word MarkPROTAGONIST THERAPEUTICS
Filing DateWednesday, May 29, 2019
Status700 - REGISTERED
Status DateTuesday, September 1, 2020
Registration Number6142951
Registration DateTuesday, September 1, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements


Description of MarkThe mark consists of the word "Protagonist" in black above the word "Therapeutics" in orange to the right of the words is a DNA double helix in the colors black and orange. The entire mark is on a transparent background.
Certificate of Correction for RegistrationIn the statement, line 1, "CALIFORNIA" should be deleted, and "DELAWARE" should be inserted.
Indication of Colors claimedThe color(s) black and orange is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesSCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; TECHNICAL AND SCIENTIFIC CONSULTATION AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS, IN THE FIELD OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND TO PHARMACEUTICALS; PROVIDING ON-LINE INFORMATION FOR MEDICAL RESEARCH PURPOSES, IN THE FIELDS OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, TREATMENTS FOR IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND PHARMACEUTICALS

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 13, 2019
Primary Code042
First Use Anywhere DateTuesday, May 10, 2016
First Use In Commerce DateTuesday, May 10, 2016

Trademark Owner History


Party NameProtagonist Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Party NameProtagonist Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Party NameProtagonist Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Tuesday, November 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 17, 2021CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, March 11, 2021SEC 7 REQUEST FILED
Thursday, September 16, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, July 7, 2021POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, July 6, 2021POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, July 6, 2021POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, July 6, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 11, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, September 1, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, July 25, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 24, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 23, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 2, 2020USE AMENDMENT FILED
Thursday, July 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 2, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2019ASSIGNED TO LIE
Wednesday, November 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 21, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, August 21, 2019PRIORITY ACTION E-MAILED
Wednesday, August 21, 2019PRIORITY ACTION WRITTEN
Monday, August 19, 2019ASSIGNED TO EXAMINER
Friday, June 14, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 1, 2019NEW APPLICATION ENTERED